科華恆盛(002335.SZ):子公司擬向銀行申請項目貸款2.1億元
格隆匯 10 月 23日丨科華恆盛(002335.SZ)公佈,根據公司發展規劃及資金使用安排,為保證公司全資子公司清遠國騰計算科技有限公司(“清遠國騰”)的數據中心項目順利開展,清遠國騰擬為該項目向中國工商銀行股份有限公司廈門軟件園支行(“工行廈門軟件園支行”)申請項目貸款人民幣2.1億元(貸款期限10年),由公司為該項目貸款提供連帶責任保證擔保。
清遠國騰的上述資產目前不存在抵押或者其他第三人權利,也未涉及資產爭議、訴訟或仲裁事項,未被查封、凍結。公司及控股子公司與工行廈門軟件園支行無關聯關係,同時公司的實際控制人、控股股東及其控股子公司與工行廈門軟件園支行亦不存在關聯關係。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.